Prestige Consumer Healthcare (PBH) Raised to Sell at ValuEngine

Share on StockTwits

ValuEngine upgraded shares of Prestige Consumer Healthcare (NYSE:PBH) from a strong sell rating to a sell rating in a research report sent to investors on Monday morning, ValuEngine reports.

PBH has been the topic of several other research reports. Zacks Investment Research downgraded Prestige Consumer Healthcare from a hold rating to a sell rating in a research note on Wednesday, January 16th. Raymond James downgraded Prestige Consumer Healthcare from an outperform rating to a market perform rating and set a $28.40 target price on the stock. in a research note on Tuesday, January 15th. Royal Bank of Canada reaffirmed a buy rating and set a $97.00 target price on shares of Prestige Consumer Healthcare in a research note on Friday, March 15th. Finally, Desjardins downgraded Prestige Consumer Healthcare to a hold rating and set a $88.00 price objective on the stock. in a research note on Wednesday, February 13th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the stock. Prestige Consumer Healthcare currently has a consensus rating of Hold and an average target price of $54.07.

Shares of NYSE PBH opened at $29.41 on Monday. Prestige Consumer Healthcare has a fifty-two week low of $26.25 and a fifty-two week high of $41.76. The company has a quick ratio of 1.34, a current ratio of 2.28 and a debt-to-equity ratio of 1.49. The company has a market cap of $1.52 billion, a price-to-earnings ratio of 11.40, a price-to-earnings-growth ratio of 1.66 and a beta of 0.96.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings data on Thursday, February 7th. The company reported $0.73 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.71 by $0.02. The business had revenue of $241.40 million during the quarter, compared to analyst estimates of $241.40 million. Prestige Consumer Healthcare had a return on equity of 11.85% and a net margin of 6.44%. The business’s revenue for the quarter was down 10.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.70 EPS. Equities analysts expect that Prestige Consumer Healthcare will post 2.77 earnings per share for the current fiscal year.

Several hedge funds have recently modified their holdings of PBH. First Hawaiian Bank grew its holdings in shares of Prestige Consumer Healthcare by 218.4% during the fourth quarter. First Hawaiian Bank now owns 1,210 shares of the company’s stock valued at $37,000 after buying an additional 830 shares in the last quarter. FNY Investment Advisers LLC purchased a new position in shares of Prestige Consumer Healthcare during the fourth quarter valued at $37,000. Financial Gravity Wealth Inc. purchased a new position in shares of Prestige Consumer Healthcare during the first quarter valued at $50,000. Quadrant Capital Group LLC grew its holdings in shares of Prestige Consumer Healthcare by 2,979.3% during the first quarter. Quadrant Capital Group LLC now owns 1,786 shares of the company’s stock valued at $53,000 after buying an additional 1,728 shares in the last quarter. Finally, Captrust Financial Advisors grew its holdings in shares of Prestige Consumer Healthcare by 23.8% during the fourth quarter. Captrust Financial Advisors now owns 2,228 shares of the company’s stock valued at $69,000 after buying an additional 428 shares in the last quarter.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

See Also: What is the balance sheet?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.